These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 19663954

  • 1. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
    Madrid C, Sanz M.
    Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
    [Abstract] [Full Text] [Related]

  • 2. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy.
    Mozzati M, Arata V, Giacomello M, Del Fabbro M, Gallesio G, Mortellaro C, Bergamasco L.
    J Craniofac Surg; 2015 May; 26(3):749-55. PubMed ID: 25974785
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 4. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review.
    Javed F, Almas K.
    J Periodontol; 2010 Apr; 81(4):479-84. PubMed ID: 20367090
    [Abstract] [Full Text] [Related]

  • 5. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A, Bettini G, Totola A, Saia G, Nocini PF.
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
    [Abstract] [Full Text] [Related]

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 7. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A, Bartold M, Sambrook P, Hawker P.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [Abstract] [Full Text] [Related]

  • 8. Dental Implant Failure in Post-Menopausal Women on Oral Bisphosphonates: A Systematic Review and Meta-Analysis.
    Pishan B, Andrukhov O, Rausch-Fan X.
    J Oral Implantol; 2024 Jun 01; 50(3):288-295. PubMed ID: 38660740
    [Abstract] [Full Text] [Related]

  • 9. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep 01; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 10. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov 01; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
    Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mücke T, Mast G, Köhnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Stürzenbaum SR, Schieker M, Pautke C.
    J Craniomaxillofac Surg; 2011 Jun 01; 39(4):272-7. PubMed ID: 20580566
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report.
    Wang HL, Weber D, McCauley LK.
    J Periodontol; 2007 Mar 01; 78(3):584-94. PubMed ID: 17335384
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
    Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N.
    J Oral Maxillofac Surg; 2010 Apr 01; 68(4):790-6. PubMed ID: 20307764
    [Abstract] [Full Text] [Related]

  • 19. Oral bisphosphonates and dental implants.
    McLeod NM.
    J Oral Maxillofac Surg; 2009 Jun 01; 67(6):1355. PubMed ID: 19446233
    [No Abstract] [Full Text] [Related]

  • 20. Oral implant survival in patients with bisphosphonate (BP)/antiresorptive and radiation therapy and their impact on osteonecrosis of the jaws. A systematic review.
    Schmitt CM, Buchbender M, Lutz R, Neukam FW.
    Eur J Oral Implantol; 2018 Jun 01; 11 Suppl 1():S93-S111. PubMed ID: 30109302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.